KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.115
-0.005 (-4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
0.114
-0.001 (-0.87%)
Pre-market: Apr 29, 2026, 6:29 AM EDT

KALA BIO Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
106.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20223.89M-7.35M-65.37%
Dec 31, 202111.24M4.88M76.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Verrica Pharmaceuticals 35.58M
Seer, Inc. 16.58M
Pyxis Oncology 13.86M
Cibus 3.64M
NeOnc Technologies Holdings 39.99K
InflaRx 34.44K
Genelux 8.00K
Revenue Rankings